by John Conrad | Aug 8, 2025 | iBIO in the News
Of the $1.24 billion in venture investments pumped into Illinois’ life sciences sector last year, about half went to the state’s late-stage companies, Series A rounds accounted for 35% and early-stage companies collected 15% of the funding, according to a...
by John Conrad | Jun 10, 2019 | Policy News, PolicyFeature1
iBIO promotes thoughtful legislative and regulatory solutions that allow our member companies to research, develop, and commercialize breakthrough therapies and cures, and to ensure patients have affordable access to those new treatments. Likewise, iBIO opposes...
